Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Pre-treatment for Diltiazem-Induced Hypotension in AFF RVR
NCT05661942Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of calcium gluconate in Drug-induced hypotension (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Mean Difference in Systolic Blood Pressure. Started Nov 2022; status: completed.
02
Drugs
calcium gluconate
03
Conditions
Drug-induced hypotension
Beyond the preview
Go deeper on NCT05661942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05661942.